All Type of News
Dong-wha licensing in a new technology for anti-viral drugs
Dong-wha announced to license in a new technology development for an anti-viral drug using natural plants from Korea Bio Engineering Research Institute, which was accomplished by the chief researcher Kwon Doo-han of t...
KPA and KPWA to discuss joint clean up campaign against unfair trade
The Korea Pharmaceutical Association (KPA) and the Korea Pharmaceutical Wholesalers Association (KPWA) agreed to make a joint clean up campaign against the unfair drug distribution activities at the Pharmacist's House...
New drug screening technologies transferring to overseas
A screening technology for the discovery of new drugs has been transferred to the overseas.
The Korea Health Industry Development Institute (KHIDI) announced that the screening system technologies for the developme...
Mr. Manuel Flores assigned to CEO of Bayer Korea.The top position of Bayer Healthcare in vacant so far has been occupied by Mr. Manuel Flores who comes from Venezuela as of May 1, 2005.
He served in Thailand and the Philipp...
|
Enbrel reimbursable for ankylosing spondylitis.
Enbrel injection of Wyeth Korea has been approved of its NHI reimbursement for the indication of ankylosing spondylitis effective from May. Now, the portion of patient's payment for Enbrel has been cut down to 260 tho...
Jeil to study stem cells for Parkinson disease
Dr. Cho Myeong-soo and associates of Jeil Central Research Lab. announced to initiate a stem cell research for the treatment of Parkinson disease based on their research experiences in the nerve cell division.
Park...
New Drug R&D targeting more to commercialize
The Korea Society of Pharmaceutics (chairman: Shin Sang-cheol) took a symposium in a celebrating event of "A month of science" at Samsung Convention Center of SNU on April 29. In the conference, Dr. Shim Chang-goo, t...
Civil medical insurances may cause bipolar effects.
Prof. William Shao of Harvard Univ delivered a special lecture sponsored by the Korea Health Insurance Corporation (NIHC) on April 29, saying that a heavier reliance of medical insurance on the private civil sectors i...
Domestic industry capable to adopt global business strategies.
Many domestic drug companies are driving their diverse strategies for the global business in order to leap up as a global healthcare enterprise after realizing the limit of its growth in the domestic markets.
Most ...
HIRA to disclose review guideline for medication expenses
The Health Insurance Review Agency (HIRA) announced that the pre-notification period of the review guideline would be extended from the current 2 weeks to 1 month in advance by declaring on the day one of each month (...
